{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-10-02",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "82705-002",
      "generic_name": "epcoritamab-bysp",
      "labeler_name": "Genmab US, Inc.",
      "brand_name": "EPKINLY",
      "active_ingredients": [
        {
          "name": "EPCORITAMAB",
          "strength": "4 mg/.8mL"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "82705-002-01",
          "description": "1 VIAL, GLASS in 1 CARTON (82705-002-01)  / .8 mL in 1 VIAL, GLASS",
          "marketing_start_date": "20230519",
          "sample": false
        }
      ],
      "listing_expiration_date": "20271231",
      "openfda": {
        "manufacturer_name": [
          "Genmab US, Inc."
        ],
        "rxcui": [
          "2637399",
          "2637405",
          "2637408",
          "2637411"
        ],
        "spl_set_id": [
          "d7836711-b677-412d-bf2d-0f7c8444103a"
        ],
        "is_original_packager": [
          true
        ],
        "nui": [
          "N0000194063",
          "N0000175078",
          "N0000175617",
          "N0000175618",
          "N0000009267",
          "N0000182136"
        ],
        "pharm_class_epc": [
          "Bispecific CD20-directed CD3 T Cell Engager [EPC]"
        ],
        "pharm_class_moa": [
          "CD20-directed Antibody Interactions [MoA]",
          "CD3-directed Antibody Interactions [MoA]",
          "CD3 Receptor Agonists [MoA]",
          "Cytochrome P450 Inhibitors [MoA]"
        ],
        "pharm_class_pe": [
          "Increased Cytokine Activity [PE]"
        ],
        "unii": [
          "D6OMY2L0WA"
        ]
      },
      "marketing_category": "BLA",
      "dosage_form": "INJECTION, SOLUTION",
      "spl_id": "e2f39a72-c677-4ded-a10c-da739f457180",
      "product_type": "HUMAN PRESCRIPTION DRUG",
      "route": [
        "SUBCUTANEOUS"
      ],
      "marketing_start_date": "20230519",
      "product_id": "82705-002_e2f39a72-c677-4ded-a10c-da739f457180",
      "application_number": "BLA761324",
      "brand_name_base": "EPKINLY",
      "pharm_class": [
        "Bispecific CD20-directed CD3 T Cell Engager [EPC]",
        "CD20-directed Antibody Interactions [MoA]",
        "CD3 Receptor Agonists [MoA]",
        "CD3-directed Antibody Interactions [MoA]",
        "Cytochrome P450 Inhibitors [MoA]",
        "Increased Cytokine Activity [PE]"
      ]
    }
  ]
}